NeuroRecovery, GTX Medical merge to advance devices for spinal cord injury treatment

Written by Alan Condon | October 23, 2019 | Print  |

NeuroRecovery Technologies merged with GTX Medical to form a new neurostimulation company, GTX Medical BV.

Four insights:

1. The company is developing therapies to improve functional recovery of patients with spinal cord injuries.

2. GTX Medical BV is designing an implantable spinal cord stimulation device with real-time motion feedback known as targeted epidural spine stimulation.

3. The company is also developing a transcutaneous spinal cord stimulation device to restore upper limb movement and hand function.

4. The Christopher & Dana Reeve Foundation, a nonprofit focused on advancing spinal cord injury research, will be a shareholder in the company.

More articles on devices:
7 big moves for Hospital for Special Surgery in 2019
5 highest paying physician specialties — Neurosurgeon No. 1 at $401k
Dr. Thomas Loftus: How a single-payer system would harm spine practice in the US

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers